David Nemirovsky - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

David Nemirovsky

Showing results (31-40 of 33) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 33 results.

Blood Cancer Journal|September 19, 2024

Colesevelam for lenalidomide associated diarrhea in patients with multiple myelomaMalin Hultcrantz, Hani Hassoun, Neha Korde, et al.

Blood Advances|October 31, 2025

Derivation and External Validation of a Venous Thromboembolism Risk Prediction Model in Asparaginase-Treated ALLDaniela R Anderson, Radhika Gangaraju, Wafik G Sedhom, et al.

Blood Advances|October 6, 2025

CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemiaYannis K Valtis, Chenyu Lin, David Nemirovsky, et al.

Pageof 4

Search research articles

Showing results (31-40 of 33) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 33 results.

Blood Cancer Journal|September 19, 2024

Colesevelam for lenalidomide associated diarrhea in patients with multiple myelomaMalin Hultcrantz, Hani Hassoun, Neha Korde, et al.

Blood Advances|October 31, 2025

Derivation and External Validation of a Venous Thromboembolism Risk Prediction Model in Asparaginase-Treated ALLDaniela R Anderson, Radhika Gangaraju, Wafik G Sedhom, et al.

Blood Advances|October 6, 2025

CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemiaYannis K Valtis, Chenyu Lin, David Nemirovsky, et al.

Pageof 4